Tradestie Institutional Equity Comparison Engine

TVTX vs BHVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TVTX Overall Edge

TVTX Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Travere Therapeutics, Inc. Common Stock (TVTX) driven by superior Valuation, Options & Structure while BHVN counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, TVTX trades at 9.3x Forward P/E with -3.1% operating margin (+36.2% YoY revenue) versus BHVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, TVTX sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TVTX
TVTX 9.3x vs BHVN N/M Fwd P/E
Growth & Margin Winner BHVN
Op Margin -3.1% vs 0.0% ยท YoY +36.2% vs +0.0%
Momentum & Technical Winner BHVN
1Y +47.7% vs +72.6% ยท 52W Pos 60% vs 59%
Options & Structure Winner TVTX
CONSOLIDATION (6th %ile IV) vs CONSOLIDATION (18th %ile IV)
TVTX NASDAQ
Travere Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$50.05
-1.18% 1D
Market Cap $4.9B
1M Return +0.91%
1Y Return +47.68%
Forward P/E 9.3x
Unified AI Score
60.2 / 100 BUY
Tech 47.0 Fund 57.0 Flow 64.0 Mom 64.0
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.95
+0.9% 1D
Market Cap $2.1B
1M Return +29.36%
1Y Return +72.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TVTX +47.68% BHVN +72.59% Spread: +24.91 pp (BHVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TVTX TTM Op. Margin: -3.1% BHVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TVTX vs BHVN. Trailing 12-month operating profitability (TVTX -3.1% vs BHVN 0.0%) and valuation multiples (TVTX 9.3x vs BHVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TVTX (8) vs BHVN (2)
Institutional Metric TVTX BHVN Criterion Row Winner
Market Capitalization Scale $4.9B $2.1B Larger Scale TVTX
Trailing P/E Ratio Valuation 25.8x N/M Lower Multiple TVTX
Forward P/E Ratio Valuation 9.3x N/M Lower Multiple TVTX
Revenue Growth (YoY) Growth +36.2% +0.0% Higher Growth TVTX
Operating Margin (TTM) Profitability -3.1% 0.0% Higher Margin BHVN
Net Profit Margin Profitability -18.7% 0.0% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -321.2% -799.5% Higher ROE TVTX
52-Week Range Position Momentum 60% ($23โ€“$69) 59% ($8โ€“$18) Stronger Trend TVTX
Beta / 30D Volatility Risk Regime 1.39ฮฒ ยท 44% Vol 1.40ฮฒ ยท 111% Vol Lower Realized Risk TVTX
Unified Institutional Score Composite Signal 60.2 / 100 (BUY) 42.1 / 100 (HOLD) Higher Composite TVTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TVTX vs BHVN Buy Guide
TVTX CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live TVTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TVTX nor BHVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.